Re: #2, I’ve argued for minimal institutions where possible—relying on markets or existing institutions rather than building new ones, where possible.
For instance, instead of setting up a new organization to fund a certain type of prize, see if you can pay an insurance company to “insure” the risk of someone winning, as determined by some criteria, and them have them manage the financials. Or, as I’m looking at for incentifying building vaccine production now, offer cheap financing for companies instead of running a new program to choose and order vaccines to get companies to produce them.
Re: #2, I’ve argued for minimal institutions where possible—relying on markets or existing institutions rather than building new ones, where possible.
For instance, instead of setting up a new organization to fund a certain type of prize, see if you can pay an insurance company to “insure” the risk of someone winning, as determined by some criteria, and them have them manage the financials. Or, as I’m looking at for incentifying building vaccine production now, offer cheap financing for companies instead of running a new program to choose and order vaccines to get companies to produce them.
Thanks, makes sense.
Also, strongly agree on #3 - see my post from last year: https://forum.effectivealtruism.org/posts/yQWYLaCgG3L6H2Lya/challenges-in-scaling-ea-organizations